Suchergebnisse - (Subject:"Drug repurposing")

PubPharm (4.758)

41

scDrugPrio : a framework for the analysis of single-cell transcriptomics to address multiple problems in precision medicine in immune-mediated inflammatory diseases

enthalten in: Genome medicine | 2024

von Schäfer, S. | Smelik, M. | Sysoev, O. | +14

UpdateOf: bioRxiv. 2023 Nov 13;:. - PMID 38014022

42

"Keep on ROCKIn" : Repurposed ROCK inhibitors to boost corneal endothelial regeneration

enthalten in: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie | 2024

von Vercammen, H. | Ondra, M. | Kotulova, J. | +9

43

Repurposing of Compounds from Streptomyces spp. as Potential Inhibitors of Aminoacyltransferase FemA : An Essential Drug Target against Drug-resistant Staphylococcus aureus

enthalten in: Current computer-aided drug design | 2024

von Goodarzi, N. | Shahbazi, B. | Khiavi, E. | +3

44

scDrugPrio: a framework for the analysis of single-cell transcriptomics to address multiple problems in precision medicine in immune-mediated inflammatory diseases

enthalten in: Genome medicine | 2024

von Schäfer, S. | Smelik, M. | Sysoev, O. | +14

45

Targeting of essential mycobacterial replication enzyme DnaG primase revealed Mitoxantrone and Vapreotide as novel mycobacterial growth inhibitors

enthalten in: Molecular informatics | 2024

von Ali, W. | Jamal, S. | Gangwar, R. | +6

46

Repurposing empagliflozin in individuals with glycogen storage disease Ib : A value-based healthcare approach and systematic benefit-risk assessment

enthalten in: Journal of inherited metabolic disease | 2024

von Derks, T. | Venema, A. | Köller, C. | +9

47

Drug repurposing platform for deciphering the druggable SARS-CoV-2 interactome

enthalten in: Antiviral research | 2024

von Bogacheva, M. | Kuivanen, S. | Potdar, S. | +16

48

Drug repurposing screen identifies novel anti-inflammatory activity of sunitinib in macrophages

enthalten in: European journal of pharmacology | 2024

von Chaffey, L. | Roberti, A. | Bowman, A. | +4

49

Doxazosin inhibits vasculogenic mimicry in human non‑small cell lung cancer through inhibition of the VEGF‑A/VE‑cadherin/mTOR/MMP pathway

enthalten in: Oncology letters | 2024

von Hsu, J. | Leu, W. | Hsu, L. | +2

50

Repurposing of US-FDA-approved drugs as negative modulators of ubiquitin specific protease-7 (USP7)

enthalten in: Heliyon | 2024

von Zadi, S. | Javaid, S. | Atia-Tul-Wahab | +4